Company Filing History:
Years Active: 2024
Title: Lida Kimmel: Innovator in Cancer Treatment
Introduction
Lida Kimmel is a notable inventor based in Chester, CT (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic antibodies.
Latest Patents
Lida Kimmel holds a patent for "Anti-MET antibodies and methods of use thereof." This patent involves compositions, methods, and uses of antibodies that specifically bind to MET, a receptor tyrosine kinase. These antibodies modulate the expression and/or activity of MET, providing potential methods for managing, treating, or preventing disorders such as cancer. The patent also describes a monoclonal antibody or antigen-binding fragment that binds to the Sema/PSI domain of human MET. Additionally, it includes a kit comprising the antibody or antigen-binding fragment and outlines a method for treating cancer in a subject by administering a therapeutically effective amount of the antibody.
Career Highlights
Lida Kimmel is associated with Celldex Therapeutics Limited, where she continues to advance her research in the field of oncology. Her work focuses on developing innovative solutions to combat cancer, showcasing her dedication to improving patient outcomes.
Collaborations
Lida collaborates with esteemed colleagues such as Yan Yang and Sreekala Mandiyan, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Lida Kimmel's contributions to cancer treatment through her patented innovations highlight her role as a leading inventor in the field. Her work not only advances scientific knowledge but also holds the potential to significantly impact patient care.